First human tests begin for mystery drug AZD1613
NCT ID NCT06995820
Summary
This is the first study in people for a new drug called AZD1613, made by AstraZeneca. It aims to check if the drug is safe, how the body handles it, and what it does in healthy volunteers, including people of Chinese and Japanese descent. The study will give the drug at different doses, either as a single shot or several shots over time, and compare it to a placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGGlendale, California, 91206, United States
Conditions
Explore the condition pages connected to this study.